The influence of a single and double biotinylation of xanthohumol on its anticancer activity

Two biotinylated derivatives of the main hop chalcone xanthohumol (1) were prepared by a one-step synthesis via esterification using biotin and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC×HCl) and 4-dimethylaminopyridine (DMAP) as coupling reagents. The products were characteriz...

Full description

Saved in:
Bibliographic Details
Published inActa biochimica Polonica Vol. 66; no. 4; p. 559
Main Authors Stompor, Monika, Świtalska, Marta, Wietrzyk, Joanna
Format Journal Article
LanguageEnglish
Published Poland 10.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Two biotinylated derivatives of the main hop chalcone xanthohumol (1) were prepared by a one-step synthesis via esterification using biotin and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC×HCl) and 4-dimethylaminopyridine (DMAP) as coupling reagents. The products were characterized spectroscopically and their antiproliferative activity toward MCF-7, MCF-10A, HepG2, MDA-MB-231, 4T1 and Balb/3T3 cell lines was investigated using the SRB assay. For all three tested compounds the best activity was noted in the case of human (MCF-7) and mice (4T1) breast cancer cell lines (IC50 values < 9 μM). Both biotinylated derivatives showed slightly higher anticancer activity than xanthohumol (1) towards all types of tested breast cancer cells. Double biotinylated xanthohumol (3) proved to be the most active in inhibiting cell growth, with IC50 values equal to 5.35 ± 1.5 μM for 4T1 and 8.03 ± 0.53 µM for MCF-7 cell lines. Compound 3 was also more active than 1 and 2 against liver cancer cells HepG2 (IC50 = 17.37 ± 5.1 μM), while the IC50 values for 1 and 2 were equal to 21.5 ± 2.7 and 22.1 ± 3.9 µM, respectively. 4‑O‑biotinylxanthohumol (2) was the second most active growth inhibitor, particularly with respect to MCF-7 (IC50 = 6.19 ± 1.7 μM) and 4T1 (IC50 = 6.64 ± 0.4 μM) cell lines. Our preliminary study on biotinylated xanthohumol (1) have shown that this type of functionalization is an effective method for the production of active biomolecules and study on this area should be continued thereby extending their applications.
AbstractList Two biotinylated derivatives of the main hop chalcone xanthohumol (1) were prepared by a one-step synthesis via esterification using biotin and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC×HCl) and 4-dimethylaminopyridine (DMAP) as coupling reagents. The products were characterized spectroscopically and their antiproliferative activity toward MCF-7, MCF-10A, HepG2, MDA-MB-231, 4T1 and Balb/3T3 cell lines was investigated using the SRB assay. For all three tested compounds the best activity was noted in the case of human (MCF-7) and mice (4T1) breast cancer cell lines (IC50 values < 9 μM). Both biotinylated derivatives showed slightly higher anticancer activity than xanthohumol (1) towards all types of tested breast cancer cells. Double biotinylated xanthohumol (3) proved to be the most active in inhibiting cell growth, with IC50 values equal to 5.35 ± 1.5 μM for 4T1 and 8.03 ± 0.53 µM for MCF-7 cell lines. Compound 3 was also more active than 1 and 2 against liver cancer cells HepG2 (IC50 = 17.37 ± 5.1 μM), while the IC50 values for 1 and 2 were equal to 21.5 ± 2.7 and 22.1 ± 3.9 µM, respectively. 4‑O‑biotinylxanthohumol (2) was the second most active growth inhibitor, particularly with respect to MCF-7 (IC50 = 6.19 ± 1.7 μM) and 4T1 (IC50 = 6.64 ± 0.4 μM) cell lines. Our preliminary study on biotinylated xanthohumol (1) have shown that this type of functionalization is an effective method for the production of active biomolecules and study on this area should be continued thereby extending their applications.
Author Wietrzyk, Joanna
Świtalska, Marta
Stompor, Monika
Author_xml – sequence: 1
  givenname: Monika
  surname: Stompor
  fullname: Stompor, Monika
  organization: Faculty of Medicine, Centre for Innovative Research in Medical and Natural Sciences, University of Rzeszów, Warzywna 1a, 35-310 Rzeszów Poland
– sequence: 2
  givenname: Marta
  surname: Świtalska
  fullname: Świtalska, Marta
  organization: Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Department of Experimental Oncology, Wrocław, Poland
– sequence: 3
  givenname: Joanna
  surname: Wietrzyk
  fullname: Wietrzyk, Joanna
  organization: Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Department of Experimental Oncology, Wrocław, Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31820895$$D View this record in MEDLINE/PubMed
BookMark eNo9kEtLAzEUhYNU7EO3LiV_YGoeM5PMshZfUNBFhS6EIcnc2Mg0KTMZsf_eaNXNvZfLdw6HM0UjHzwgdEnJnEou5fXi5nnOCK1qJkV5giZU8DyjRb4ZoQkhhGYFE5sxmvb9OyGM0yo_Q2NOJSOyKibodb0F7LxtB_AGcLBY4d75txaw8g1uwqDTqV2Izh9aFV3w39Cn8nEbtsMutDh9XOwTHp1RyaTDykT34eLhHJ1a1fZw8btn6OXudr18yFZP94_LxSozrCpiJjSUQpbCUEjxAIwUDbUmjbxqCiO5ZoUiJdCS5sqI0iotjDDQ5JqTilo-Q_Ojr-lC33dg633ndqo71JTUPzXVSu_r_5qS4Ooo2A96B80__tcL_wJtgWce
CitedBy_id crossref_primary_10_3390_nu13093043
crossref_primary_10_3390_ijms222312889
crossref_primary_10_1021_acs_jmedchem_3c00238
crossref_primary_10_3390_nu13062038
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.18388/ABP.2019_2876
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1734-154X
ExternalDocumentID 10_18388_abp_2019_2876
31820895
Genre Journal Article
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
-~X
23M
2WC
3EA
5GY
5RE
6J9
6S1
9T4
AAFWJ
AAYXX
ABMXE
ACGFO
ADBBV
AEGXH
AENEX
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
DIK
E3Z
EBD
EBS
EJD
EMOBN
EOJEC
F5P
GROUPED_DOAJ
GX1
HH5
L7B
M~E
OBODZ
OK1
P2P
RNS
SV3
TR2
XSB
Y2W
ID FETCH-LOGICAL-c295t-7be67867c1e194eec87d1fc7d149d5c83b25a06e1614ac76fab7c7ced4b3091f3
ISSN 0001-527X
IngestDate Fri Aug 23 02:26:02 EDT 2024
Sat Sep 18 05:00:16 EDT 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c295t-7be67867c1e194eec87d1fc7d149d5c83b25a06e1614ac76fab7c7ced4b3091f3
ORCID 0000-0003-4980-6606
0000-0001-5618-8899
PMID 31820895
ParticipantIDs crossref_primary_10_18388_abp_2019_2876
pubmed_primary_31820895
PublicationCentury 2000
PublicationDate 2019-Dec-10
PublicationDateYYYYMMDD 2019-12-10
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-Dec-10
  day: 10
PublicationDecade 2010
PublicationPlace Poland
PublicationPlace_xml – name: Poland
PublicationTitle Acta biochimica Polonica
PublicationTitleAlternate Acta Biochim Pol
PublicationYear 2019
SSID ssj0023194
Score 2.355679
Snippet Two biotinylated derivatives of the main hop chalcone xanthohumol (1) were prepared by a one-step synthesis via esterification using biotin and...
SourceID crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 559
SubjectTerms Animals
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
BALB 3T3 Cells
Biotinylation - genetics
Breast Neoplasms - drug therapy
Breast Neoplasms - genetics
Cell Proliferation - drug effects
Cell Survival - drug effects
Female
Flavonoids - chemistry
Flavonoids - pharmacology
Hep G2 Cells
Humans
Liver Neoplasms - drug therapy
Liver Neoplasms - genetics
MCF-7 Cells
Mice
Propiophenones - chemistry
Propiophenones - pharmacology
Title The influence of a single and double biotinylation of xanthohumol on its anticancer activity
URI https://www.ncbi.nlm.nih.gov/pubmed/31820895
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLZgCIkLgo0fGzD5wOAUSJo4jo_VxDYhbUJik3pAivwrWtQuQSXV6P563rMTd5162LhYlRO7ld9X-3u23_sI-ZjphJlkhPtfQkUZl_CfM0ZFzKjY6Cw2scAA59Oz_OQi-z5hk5XGposu6dQXfbMxruR_rAp1YFeMkn2AZUOnUAGfwb5QgoWhvLeN60FlxEc6ous_80cCpl1gWJSq265ulrPADf9KTBhwubhqZ3hUgCcHUIPTobZzl1wD9SRus9ax7iT2oy9rzC6Ayg6YUTfM6D-7FhNcuc1VeDANDw4O2YEYX6MwyZ-p7GODutVKUNtufrOc-m182Xgl72ETInEKCv111GFiTcCndar3sKz4uZSnWQQMbbJxpi7SAsMPpMKkoYkowXPbkBL7zlIVLhCi64I9lNC-DO0fkycjLhje7DyehJs-wGCFT8bd_8Y-dye2_7r2_WvcZM3LcGzj_AV53rsJdOxt_pI8ss022Rk3EkZ6ST9Rd3HXnYhsk6deT3S5Q34BIGgABG0rKqkHBAVAUA8IugYIfOkWICjUACDoChB0AMQrcnH07fzwJOrlMyI9EqyLuLLARHKuEwsDYK0uuEkqDUUmDNNFqkZMxrkFzp9JzfNKKq65tiZTKbDIKn1Ntpq2sW8JlbCuFZUB8mrTzAgrUnDdNaauY3kVS7tLPg8DV_72WVLKzSbaJW_8uIb3UpQQKATbu3cf78izFQbfk61uvrAfgBp2at9tqew780N59uP0H8l2Z7Q
link.rule.ids 315,786,790,870,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+influence+of+a+single+and+double+biotinylation+of+xanthohumol+on+its+anticancer+activity&rft.jtitle=Acta+biochimica+polonica&rft.au=Stompor%2C+Monika&rft.au=%C5%9Awitalska%2C+Marta&rft.au=Wietrzyk%2C+Joanna&rft.date=2019-12-10&rft.issn=0001-527X&rft.eissn=1734-154X&rft_id=info:doi/10.18388%2Fabp.2019_2876&rft.externalDBID=n%2Fa&rft.externalDocID=10_18388_abp_2019_2876
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-527X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-527X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-527X&client=summon